Rhode Island 2026 Regular Session

Rhode Island House Bill H7185

Introduced
1/21/26  

Caption

Provides that the prescription label for medication abortion prescription drugs may include the name of the dispensing healthcare practice instead of the name of the dispenser.

Impact

The enactment of H7185 will significantly impact the practice of labeling prescriptions within the healthcare sector, particularly in relation to medications associated with abortion services. By shifting the labeling responsibility to the healthcare practice, the bill aims to mitigate potential backlash or stigma associated with individual healthcare providers. This could encourage more providers to participate in offering medication abortion services without fear of personal repercussions, thereby potentially increasing access to this necessary healthcare option for patients.

Summary

House Bill H7185, introduced in 2026, focuses on the 'Protections for Healthcare Providers Act' by amending existing provisions related to healthcare practices. The central aim of this legislation is to enhance confidentiality for healthcare providers involved in the dispensation of medication abortion prescription drugs. Specifically, the bill allows for the prescription label for these drugs to feature the name of the healthcare practice dispensing the medication rather than the individual dispenser's name. This change is intended to foster a level of anonymity and protection for healthcare providers concerning sensitive medical transactions and processes.

Contention

While H7185 presents several benefits aimed at protecting the identity of healthcare providers, it may also spark debates regarding transparency and accountability within the healthcare system. Critics might argue that changing the labeling could obscure the individual responsibilities of healthcare providers and impede traceability in case of adverse effects or malpractice issues. Additionally, there could be concerns raised by anti-abortion groups about the implications of making abortion services less identifiable, which they may see as hindering their ability to provide informed consent information to patients. Thus, while the bill aims to provide protections, it has the potential to invoke a complex discussion around the balance between patient rights and provider safety in a contentious area of healthcare.

Companion Bills

No companion bills found.

Previously Filed As

RI S0578

Provides that the prescription label for medication abortion prescription drugs shall include the name of the dispensing health care practice instead of the name of the dispenser.

RI H6174

Provides that the prescription label for medication abortion prescription drugs shall include the name of the dispensing health care practice instead of the name of the dispenser.

RI S0476

Amends current law so that initial contraceptive prescriptions would no longer be limited to a 3-month supply.

RI H6038

Amends current law so that initial contraceptive prescriptions would no longer be limited to a 3-month supply.

RI S0166

Amends the definition of the practice of pharmacy to include the administration of all forms of influenza immunizations including COVID-19 to individuals over the age of 3 years pursuant to a valid prescription or prescriber approved protocol.

RI S0467

Establishes the Wholesale Prescription Drug Importation Program for the importation of wholesale prescription drugs from Canada, to provide savings to Rhode Island consumers.

RI H5853

Establishes the Wholesale Prescription Drug Importation Program for the importation of wholesale prescription drugs from Canada, to provide savings to Rhode Island consumers.

RI H5302

Caps the total amount that a covered person is required to pay for a covered prescription inhaler, prescription device, or prescription equipment to twenty-five dollars ($25.00) per thirty (30) day supply.

RI S0461

Caps the total amount that a covered person is required to pay for a covered prescription inhaler, prescription device, or prescription equipment to twenty-five dollars ($25.00) per thirty (30) day supply.

RI H5119

Limits the use by insurers of step therapy, a protocol that establishes a specific sequence in which prescription drugs for a specified medical condition are covered by an insurer, by allowing medical providers to request step therapy exceptions.

Similar Bills

No similar bills found.